Structure-guided development of affinity probes for tyrosine kinases using chemical genetics
Jimmy A. Blair, Kevan M. Shokat(Howard Hughes Medical Institute), Michael J. Eck(Harvard University), Daniel Rauh(TU Dortmund University), William A. Weiss(City College of San Francisco), Chao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi-Wen Fan(City College of San Francisco), Cai‐Hong Yun(Harvard University), Charles Kung(Agios Pharmaceuticals (United States)), Haridas B. Rode(Indian Institute of Chemical Technology)
Cited by 203
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k